VIVEbiotech

About:

VIVEbiotech is a GMP Contract Development and Manufacturing Organization (CDMO) specialized in Lentiviral vectors.

Top Investors: Inveready, Centre for the Development of Industrial Technology (CDTI), EASO Ventures

Description:

VIVEbiotech develops and manufactures lentiviral vectors in accordance with EMA and FDA guidelines. VIVEbiotech's lentiviral vectors are utilized to treat a variety of ailments, including haematological and solid malignancies, as well as uncommon diseases.

Total Funding Amount:

3.5M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Sebastian, Pais Vasco, Spain

Founded Date:

2015-01-01

Contact Email:

info(AT)vivebiotech.com

Founders:

Gurutz Linazasoro

Number of Employees:

51-100

Last Funding Date:

2021-06-08

IPO Status:

Private

Industries: